Middle East and Africa Poultry Vaccines Market: By Vaccine Type, By Formulation Vaccines, Liquid Vaccines, Freeze Dried Vaccines), By Application, and Country
Middle East and Africa Poultry Vaccines Market size is valued at US$ x million in 2023 and is expected to reach US$ x million by 2030, at a CAGR of x% during the forecast period 2024-2030. Vaccines are biological preparations that provide acquired immunity to particular disease in human beings or animals. Poultry vaccines are used to prevent or cure the various diseases in poultry such as Marek’s disease, Newcastle disease, and infectious diseases among others. However, stringent regulatory guidelines for vaccine approvals, lack of awareness about the poultry vaccination in underdeveloped countries, adverse effects associated with vaccines, and high cost of vaccines may hamper the growth of Middle East and Africa poultry vaccines market in future years. This report studies market dynamics elaborately to identify the current market trends and drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, market report includes competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed market to better equip clients with possible investment opportunities across the Countries (Country Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the market report include suppliers, manufacturers, marketers, policy makers, and agronomists engaged in market activities.
Rise in population demand for healthy meat and poultry products, increase in adoption newer poultry vaccines, increase in the poultry production, rise in prevalence of infectious diseases are expected to boost the Middle East and Africa poultry vaccines market over the forecast period.
Geographically, Middle East and Africa poultry vaccines market is segmented into Gulf Cooperation Council (GCC) Countries, Israel, South Africa, and Rest of Middle East and Africa. Gulf Cooperation Council (GCC) Countriespoultry vaccines market is growing due to expansion of businesses by market players, rise in number of poultry farms, increase in the prevalence of infections such as avian infectious bronchitis are expected to bolster the market. South Africa poultry vaccines marketaccounted for significant share owing to rise in awareness about poultry diseases and vaccine among veterinary professionals, increase in animal healthcare expenditure, and adoption of newer vaccines are upsurge the revenue of market.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
By Vaccine Type |
|
|
By Formulation |
|
|
By Application |
|
Download Free Sample Report
The Middle East and Africa Poultry Vaccines Market size is valued at US$ x million in 2023 and is expected to reach US$ x million by 2030, at a CAGR of x% during the forecast period 2024-2030 .
The Middle East and Africa Poultry Vaccines Market data: Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
The Middle East and Africa Poultry Vaccines Market key players are Zoetis (Pfizer, Inc.), Merck & Co. Inc., Virbac S.A. . Boehringer Ingelheim Vetmedica, Elanco , Bayer Animal Health , Phibro Animal health Corporation , Zydus AHL , Ceva Sante Animale
| 1.Executive Summary |
| 2. Middle East And Africa Poultry Vaccines Market Introduction |
| 2.1. Middle East And Africa Poultry Vaccines Market - Taxonomy |
| 2.2. Middle East And Africa Poultry Vaccines Market - Definitions |
| 2.2.1.Vaccine Type |
| 2.2.2.Formulation |
| 2.2.3.Application |
| 2.2.0.Country |
| 3. Middle East And Africa Poultry Vaccines Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4. Middle East And Africa Poultry Vaccines Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
| 4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Middle East And Africa Poultry Vaccines Market By Vaccine Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 5.1. Inactivated Vaccines |
| 5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Live Attenuated Vaccines |
| 5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Recombinant Vaccines |
| 5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 6. Middle East And Africa Poultry Vaccines Market By Formulation, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 6.1. Dry Form (Duct) Vaccines |
| 6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Liquid Vaccines |
| 6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Freeze Dried Vaccines |
| 6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 7. Middle East And Africa Poultry Vaccines Market By Application, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 7.1. Mareks Disease |
| 7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Newcastle Disease |
| 7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Infectious Bursal Disease |
| 7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Infectious Bronchitis |
| 7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Others |
| 7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 8. Middle East And Africa Poultry Vaccines Market By Country, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 8.1. Middle East and Africa (MEA) |
| 8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. GCC Countries |
| 8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. South Africa |
| 8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Rest of MEA |
| 8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 9. Competition Landscape |
| 9.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 9.2.1.Zoetis (Pfizer, Inc.) |
| 9.2.2.Merck & Co. Inc. |
| 9.2.3.Boehringer Ingelheim Vetmedica |
| 9.2.4.Elanco |
| 9.2.5.Bayer Animal Health |
| 9.2.6.Ceva Sante Animale |
| 9.2.7.Zydus AHL |
| 9.2.8.Hester Biosciences Limited. |
| 10. Research Methodology |
| 11. Appendix and Abbreviations |
Key Market Players
Author
Manoj Kumar is a postgraduate in Life Sciences with over seven years of dedicated experience in the fields of animal health and agriculture. His passion lies in unraveling the complexities of these domains through rigorous research and practical insights. Manoj Kumar’s journey has been marked by several key achievements: as a market analyst and competitive intelligence expert, he dissects data to provide actionable insights for global clients. Simultaneously, he champions animal healthcare, diagnosing ailments, and designing preventive care strategies. In the realm of agriculture, his focus on sustainable practices, emphasizing crop nutrition, soil health, and precision agriculture. His holistic approach and commitment to advancing science make him a respected figure in the ever-evolving landscape of life sciences.
Download Free Sample
